Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat with Paclitaxel and Carboplatin in Recurrent Ovarian Cancer
NCT00772798Phase 2Unknown
- Sponsor
- Herlev Hospital
- Start
- Jun 2007
- Primary completion
- Jun 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by Herlev Hospital. Status: unknown.
02
Drugs
vorinostat
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00772798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772798.